In line with this, PGRMC1 silencing favored an enhanced NFAT1 accumulation in cells treated with P4 (Figure 9), thus favoring cell proliferation similar to that in prostate cancer cells [71,72]. The gene discussed is NFATC2; the disease is Familial prostate cancer.